Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» myelodysplastic syndrome
myelodysplastic syndrome
Patient death spurs trial halt for Magenta Therapeutics
Patient death spurs trial halt for Magenta Therapeutics
Endpoints
Magenta Therapeutics
MGTA-117
clinical trials
patient deaths
AML
myelodysplastic syndrome
Flag link:
Why The Magenta Therapeutics (MGTA) Stock Plummeted Over 50%
Why The Magenta Therapeutics (MGTA) Stock Plummeted Over 50%
Pulse 2.0
Magenta Therapeutics
clinical trials
MGTA-117
AML
myelodysplastic syndrome
Flag link:
With positive trial results, Bristol Myers looks to widen use of blood disease drug
With positive trial results, Bristol Myers looks to widen use of blood disease drug
BioPharma Dive
Bristol Myers Squibb
Reblozyl
myelodysplastic syndrome
Flag link:
I-Mab reports positive data from Phase II myelodysplastic syndrome trial
I-Mab reports positive data from Phase II myelodysplastic syndrome trial
Clinical Trials Arena
I-Mab
clinical trials
lemzoparlimab
myelodysplastic syndrome
Flag link:
EHA 2021 – Curis’s renaissance continues
EHA 2021 – Curis’s renaissance continues
EP Vantage
Curis
CA-4948
EHA
myelodysplastic syndrome
acute myelogenous leukemia
clinical trials
Flag link:
Onconova reports PhIII flop, putting high-risk MDS program on the chopping block
Onconova reports PhIII flop, putting high-risk MDS program on the chopping block
Endpoints
Onconova
clinical trials
Rigosertib
myelodysplastic syndrome
Flag link:
Takeda gets FDA breakthrough therapy status for pevonedistat to treat higher-risk HR-MDS
Takeda gets FDA breakthrough therapy status for pevonedistat to treat higher-risk HR-MDS
Pharmaceutical Business Review
Takeda Pharmaceuticals
breakthrough status
FDA
pevonedistat
myelodysplastic syndrome
Flag link:
This Cancer Drug Is Driving Forty Seven's Stock Higher
This Cancer Drug Is Driving Forty Seven's Stock Higher
Motley Fool
Forty Seven
magrolimab
clinical trials
myelodysplastic syndrome
Flag link:
Astex Pharma and Otsuka’s Cancer Trial Meets Primary Endpoints
Astex Pharma and Otsuka’s Cancer Trial Meets Primary Endpoints
BioSpace
Astex
Otsuka
clinical trials
ASTX727
myelodysplastic syndrome
CMML
Flag link:
Celgene and Acceleron Submit BLA for Luspatercept
Celgene and Acceleron Submit BLA for Luspatercept
CP Wire
Celgene
Acceleron
luspatercept
myelodysplastic syndrome
beta thalassemia
Flag link:
CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia
CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia
CP Wire
CytoSen
CSTD002-NK
acute myeloid leukemia
myelodysplastic syndrome
Flag link:
CytoSen Therapeutics Receives Favorable Response to Pre-IND Meeting Package for Phase 2 Study in Acute Myeloid Leukemia
CytoSen
CSTD002-NK
acute myeloid leukemia
myelodysplastic syndrome
Flag link:
Acceleron blood disease drug hits goal in pivotal clinical trial
Acceleron blood disease drug hits goal in pivotal clinical trial
Stat
Acceleron
Celgene
luspatercept
clinical trials
myelodysplastic syndrome
Flag link:
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
CP Wire
Aptevo
FDA
APVO436
AML
myelodysplastic syndrome
Flag link:
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
Aptevo
APVO436
acute myeloid leukemia
myelodysplastic syndrome
Flag link:
Geron Collaborates with J&J for Imetelstat
Geron Collaborates with J&J for Imetelstat
Yahoo/Zacks
Geron
JNJ
imetelstat
myelofibrosis
acute myelogenous leukemia
myelodysplastic syndrome
leukemia
Flag link:
Sunesis says encouraged by trial of Qinprezo
Sunesis says encouraged by trial of Qinprezo
The Fly on the Wall
Qinprexo
Sunesis
ASCO
acute myeloid leukemia
myelodysplastic syndrome
Flag link:
Can This Celgene Drug Defy the Patent Cliff?
Can This Celgene Drug Defy the Patent Cliff?
Motley Fool
patents
Celgene
myelodysplastic syndrome
Vidaza
Flag link:
Still Revving Up With Revlimid
Still Revving Up With Revlimid
Motley Fool
Revlimid
myelodysplastic syndrome
Multiple Myeloma
Celgene
Flag link:
What Is So Exciting About MEI Pharma?
What Is So Exciting About MEI Pharma?
Seeking Alpha
MEI Pharma
pracinostat
myelodysplastic syndrome
Flag link:
Pages
1
2
next ›
last »